Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

SMi’s Asthma & COPD conference next week in London

Friday, April 6, 2018 4:19
% of readers think this story is Fact. Add your two cents.
1888 PressRelease – SMi Group reports: Limited availability on Managers Special Discount.
 
Last call [Managers Special offer - £500 savings] on SMi’s Asthma & COPD conference, taking place on 11 – 12 April in London – to Directors, Principle scientists, Senior scientists, Associate directors, Managing directors, Medical directors, Pharmaceutical experts, Group leaders, Inhalation toxicologists of: clinical pharmacology; respiratory medicine/ science; respiratory immunology; pulmonary specialty; respiratory physiology.
 
Organisers are glad to welcome Richard Marsden, Chief Executive Officer of Synairgen to the speaker line-up on the Day 1 of the event
 
Event in programme in brief:
April 11 (Day 1) will have presentations covering:
Novel approaches to management and prevention of COPD exacerbations (Wisla Wedzicha of Imperial College London);
Development of inhaled interferon beta for the treatment and/or prevention of virus-induced exacerbations of Asthma and COPD (Richard Marsden, Chief Executive Officer, Synairgen);
Adherence to inhaled therapy – the challenges and opportunities of digital technologies (Richard Costello, Professor, Royal College of Surgeons in Ireland);
Regulatory requirements, human factors and usability for inhaled drug- device combination products (Quan Yang, Pharmaceutical Assessor, MHRA).
 
In addition – a number of other exciting presentations covering Novel Therapeutic Approaches to COPD & Asthma and Advancements in Inhalation Device Development.
 
April 12 (Day 2) will cover topics of:
Genetic Driven Drug Discovery for Respiratory Disease (Jonathan Phillips, Principal Scientist, Inflammation, Amgen);
New Therapeutic Targets for COPD (Peter Barnes, Professor of Thoracic Medicine and Head of Respiratory Medicine, National Heart & Lung Institute);
From efficacy to effectiveness, the Salford lung study in COPD and now asthma (David Leather, Medical Vice President, Global Respiratory Franchise, GSK)
 
In addition – multiple presentations on the following areas: Early Detection – Molecular Phenotyping and Biomarker Development, Real World Studies and Disease Modifying Drugs and The Emerging Role of Smooth Muscle in Asthma.
 
To secure £500 Managers Special Discount* register your interest at http://www.asthma-copd.co.uk/1888 or contact Kieran Ronaldson on +44 (0)20 7827 6744 / kronaldson ( @ ) smi-online dot co dot uk
 
Event is sponsored by: Vitalograph
 
Contact:
+44 (0)20 7827 6000
ldurneva ( @ ) smi-online dot co dot uk
 
STAY CONNECTED
LinkedIn – search ‘SMi Pharma’
Twitter – ( @ ) SMIpharm and #AsthmaCOPDsmi
 
Asthma & COPD | 11 – 12 April 2018 | Copthorne Tara Hotel, London, UK
http://www.asthma-copd.co.uk/1888

We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

Top Global

Top Alternative

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.